AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2013

May 18, 2013

33819_dirs_2013-05-17_e5b9d87a-a7ee-4210-8481-f8ce8807b8b6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2013-05-15

Reporting Person: MCGLYNN MARTIN M (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-15	Common Stock	F	2205	$1.84	Disposed	484664	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17009	Indirect

Footnotes

F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by him from the delivery of shares incident to the vesting of restricted stock units.

F2: Includes (1) 270,666 restricted stock units, with 135,333 of this grant vesting on each of January 27, 2014 and January 27, 2015, and (2) 40,000 restricted stock units vesting on June 25, 2013.

F3: Shares held in 401(k) account in accordance with issuer's employer-match policies.